search

Active clinical trials for "Migraine Disorders"

Results 581-590 of 1206

An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)

Migraine Headaches

A safety and efficacy study of DFN-02 (Sumatriptan Nasal Spray 10 mg), being conducted at multiple centers in the United States.

Completed19 enrollment criteria

Comparison of Oral Paracetamol and Zolmitriptan Efficacy in the Treatment of Acute Migraine in Emergency...

Acute Migraine Headache

Migraine is a chronic and sometimes progressive disorder, characterized by headache, recurrent episodes, and other associated symptoms. Migraine is the most common cause of headache among patients who applied to emergency services. The purpose of the investigators is to compare the efficacy of oral paracetamol and zolmitriptan in the treatment of acute migraine headache in an emergency department.

Completed24 enrollment criteria

An Efficacy and Tolerability Study of Topiramate in Participants With Migraine

Migraine

The purpose of this study is to investigate the adequacy (reasonably good) of topiramate therapy (medicine or medical care given to a participant for a disease or condition) in prevention of migraine (type of severe headache that occurs periodically and is often associated with nausea, vomiting, and constipation or diarrhea) by comparing standard titration (slow increase in drug dosage, guided by patient's responses) therapy to slow titration therapy and slow titration therapy boosted by the concurrent use of propranolol in participants with migraine with or without aura (having to do with the ear) for more than or equal to 2 attacks per month.

Completed10 enrollment criteria

Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents

Irritable Bowel Syndrome (IBS)Functional Abdominal Pain6 more

This protocol matches child subjects with peer mentors of similar age who have learned to function successfully with a chronic pain disorder. The trained mentors will present information to the subjects in a supervised and monitored interaction via telephone and computer for 2 months and encourage participation in skill-building programs. Children will be tested for improvement in pain and functioning at 2 months and again at 4 months to see if improvements persist. The investigators hypothesize that children who received peer mentor support will show more improvement in pain and functioning at 2 and 4 months into treatment than those in a control group who do not receive mentor support.

Completed24 enrollment criteria

A Dose-Finding Study of Topiramate (JNS019) in Participants With Migraine

Migraine

The purpose of this study is to determine a recommended dose of topiramate in participants with migraine (type of severe headache that occurs periodically and is often associated with nausea, vomiting, and constipation or diarrhea), to verify the superiority (statistically more effective) of the drug to placebo (an inactive substance that is compared with a drug to test whether the drug has a real effect in a clinical trial), and to assess if a same therapeutic effect can be observed between this study and overseas Caucasian clinical studies.

Completed10 enrollment criteria

Comparison of a Drug and Placebo in the Prevention of Migraine Headaches

HeadacheMigraine

The purpose of this study is to determine whether ethosuximide works better than placebo in the prevention of episodic migraine among veterans.

Terminated49 enrollment criteria

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

Migraine Disorders

This study was a randomized, parallel group, double-blind, placebo controlled design to compare the efficacy and tolerability of NP101 to a placebo iontophoretic transdermal patch. The primary objective of this study was to assess the proportion of subjects who were headache pain free at two hours after patch activation. Key secondary objectives included: The proportion of subjects who were nausea free at two hours after patch activation. The proportion of subjects who were photophobia free at two hours after patch activation. The proportion of subjects who were phonophobia free at two hours after patch activation.

Completed32 enrollment criteria

Efficacy and Safety of BGG492 in the Treatment of Migraine

Migraine

This study will assess the efficacy and safety of BGG492 used to treat migraine pain.

Completed10 enrollment criteria

"Completeness of Response" Following Treatment With Treximet™ for Migraine

Migraine

Many clinical trials may not fully explore criteria that are important to some migraine patients' definition of "complete response." This study offers the opportunity to evaluate the effectiveness of Treximet™ when non-standard criteria are examined (for example, neck pain, irritability or fatigue). Subjects enrolled at 8 investigative sites will complete 2 visits. Subjects will complete a Completeness of Response Survey at Visit 1 considering their usual migraine medication (a triptan) and a Completeness of Response Survey at Visit 2 considering their study medication (Treximet™).

Completed32 enrollment criteria

Acupuncture for Migraine: a Functional Magnetic Resonance Imaging (fMRI) Study

Migraine

Selecting acupoints along meridians is the predominant principle in acupuncture treatment, and it is also considered to ensure acupuncture efficacy. This experiment is to investigate whether specific brain networks gradually come in formation in accordance with this kind of acupoint selection methods.

Completed6 enrollment criteria
1...585960...121

Need Help? Contact our team!


We'll reach out to this number within 24 hrs